Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Nick Giannoukakis

University of Pittsburgh School of Medicine

Department of Pathology and Immunology

Diabetes Institute

Rangos Research Center

USA

[email]@pitt.edu

Name/email consistency: high

[Claim this account]

Affiliations

University of Pittsburgh School of Medicine, Department of Pathology and Immunology, Diabetes Institute, Rangos Research Center, USA. 2003 - 2008
Department of Pathology, University of Pittsburgh School of Medicine, PA 15213, USA. 2002 - 2005

References

Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications. Giannoukakis, N. Expert. Opin. Investig. Drugs (2008) [Pubmed]
BIM-51077, a dipeptidyl peptidase-IV-resistant glucagon-like peptide-1 analog. Giannoukakis, N. Curr. Opin. Investig. Drugs (2007) [Pubmed]
Drug evaluation: ranirestat--an aldose reductase inhibitor for the potential treatment of diabetic complications. Giannoukakis, N. Curr. Opin. Investig. Drugs (2006) [Pubmed]
Pyridoxamine (BioStratum). Giannoukakis, N. Curr. Opin. Investig. Drugs (2005) [Pubmed]
Gene therapy for type 1 diabetes: a proposal to move to the next level. Giannoukakis, N., Trucco, M. Curr. Opin. Mol. Ther. (2005) [Pubmed]
DiaPep277 (DeveloGen). Giannoukakis, N. Curr. Opin. Investig. Drugs (2005) [Pubmed]
Exenatide. Amylin/Eli Lilly. Giannoukakis, N. Curr. Opin. Investig. Drugs (2003) [Pubmed]
Fidarestat. Sanwa Kagaku/NC Curex/Sankyo. Giannoukakis, N. Curr. Opin. Investig. Drugs (2003) [Pubmed]
CJC-1131. ConjuChem. Giannoukakis, N. Curr. Opin. Investig. Drugs (2003) [Pubmed]
Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention. Giannoukakis, N., Pietropaolo, M., Trucco, M. Curr. Opin. Investig. Drugs (2002) [Pubmed]
Gene and cell therapies for diabetes mellitus: strategies and clinical potential. Giannoukakis, N., Robbins, P.D. BioDrugs (2002) [Pubmed]
Therapeutic strategies for Type 1 and Type 2 diabetes mellitus. Giannoukakis, N., Pietropaolo, M., Trucco, M. Diabetes Nutr. Metab. (2002) [Pubmed]
NBI-6024 (Neurocrine Biosciences). Giannoukakis, N. IDrugs (2002) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.